Physician

Adelina Salinas, NP

According to 2025 Medicare claims, Adelina Salinas, NP (NPI: 1306393632) practices nurse practitioner in the McAllen-Edinburg-Mission, TX market, with the plurality of this provider's patient population coming from Hidalgo, TX. This provider's primary affiliated billing organization is MONZER H YAZJI MD & ASSOCIATES PLLC (NPI: 1073508545; TIN: 752472510) and primary practice location at 78503-1728. Salinas is affiliated with the ACO REACH South Texas, LLC (ACO ID: D0276), participating under the REACH model.

Salinas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 73 traditional Medicare patients, billed 945 HCPCS/CPT codes, and received $27,147 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 6,998 prescription claims across 445 beneficiaries totaling $1,187,570 in drug costs, led by Ozempic (Semaglutide). DME data shows 22 claims. Open Payments data shows 46 records totaling $721. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $42,929 to $27,147. In contrast, Part D prescription costs have moved sharply higher in recent years, from $173,556 to $1,187,570. For DME billing, this smaller-volume category fell sharply in recent years, from $4,066 to $2,728.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	201	1,694	$42,929
2020	150	2,622	$77,243
2021	138	2,354	$68,152
2022	108	2,348	$59,841
2023	77	1,172	$35,217
2024	73	945	$27,147

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	331	1,678	$173,556
2020	425	4,761	$536,860
2021	349	5,299	$659,297
2022	383	5,927	$852,532
2023	338	6,022	$1,090,469
2024	445	6,998	$1,187,570

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	11	$251
2020	27	48	$2,562
2021	14	27	$528
2022	N/R	N/R	N/R
2023	N/R	19	$531
2024	N/R	22	$193

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	35	35	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	49	155	$67
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	46	96	$51
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	35	52	$10
36415	Insertion of needle into vein for collection of blood sample	33	57	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	286	10,728	$338,660
Mounjaro	Tirzepatide	156	5,182	$182,699
Farxiga	Dapagliflozin Propanediol	85	3,930	$72,523
Tresiba Flextouch U-100	Insulin Degludec	91	6,517	$59,746
Jardiance	Empagliflozin	49	2,640	$50,523

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0001	Standard wheelchair	Y	N/R	11	$186
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	N	N/R	11	$7

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	46	$721	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adelina Salinas, NP?

Tedicare shows public-source Medicare data for Adelina Salinas, NP (NPI 1306393632), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adelina Salinas, NP have ACO affiliation data?

Adelina Salinas, NP is shown with ACO affiliation data for ACO REACH South Texas, LLC (REACH, ACO ID D0276).

What billing organization is linked to Adelina Salinas, NP?

Adelina Salinas, NP is linked to MONZER H YAZJI MD & ASSOCIATES PLLC (billing NPI 1073508545) in the available physician profile data.

Does Adelina Salinas, NP have Open Payments data?

Adelina Salinas, NP has 46 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.